$ICUI
ICU MEDICAL INC/DE Stock $icui

$icui Overview Financials Valuation SEC Filings Company Website

2015 Q4 Form 10-K Financial Statement

#000088398417000013 Filed on March 01, 2017

Income Statement

Concept	2015 Q4	2015 Q3	2015 Q2
Revenue	$90.39M	$86.02M	$83.78M
YoY Change	13.13%	11.05%	6.49%
Cost Of Revenue	$42.10M	$39.75M	$40.02M
YoY Change	4.73%	1.12%	-2.71%
Gross Profit	$48.26M	$46.27M	$43.76M
YoY Change	21.6%	21.28%	16.57%
Gross Profit Margin	53.39%	53.79%	52.23%
Selling, General & Admin	$22.50M	$20.21M	$20.32M
YoY Change	10.84%	-7.49%	-16.31%
% of Gross Profit	46.63%	43.67%	46.43%
Research & Development	$4.100M	$4.227M	$3.122M
YoY Change	-19.61%	-16.38%	-31.63%
% of Gross Profit	8.5%	9.14%	7.13%
Depreciation & Amortization	$4.800M	$4.300M	$4.400M
YoY Change	0.0%	-12.24%	-10.2%
% of Gross Profit	9.95%	9.29%	10.05%
Operating Expenses	$26.60M	$21.50M	$23.44M
YoY Change	5.14%	-27.71%	-18.74%
Operating Profit	$21.66M	$24.77M	$20.32M
YoY Change	50.55%	194.54%	133.63%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	$100.0K	$230.0K	$240.0K
YoY Change	-50.0%	48.39%	15.94%
Pretax Income	$12.60M	$25.00M	$20.56M
YoY Change	3.28%	191.9%	130.89%
Income Tax	$7.200M	$8.732M	$6.991M
% Of Pretax Income	57.14%	34.93%	34.0%
Net Earnings	$5.463M	$16.27M	$13.57M
YoY Change	-25.9%	153.05%	130.86%
Net Earnings / Revenue	6.04%	18.91%	16.2%
Basic Earnings Per Share	$0.34	$1.02	$0.86
Diluted Earnings Per Share	$0.33	$0.98	$0.83
COMMON SHARES
Basic Shares Outstanding	15.98M shares	15.89M shares	15.78M shares
Diluted Shares Outstanding		16.58M shares	16.35M shares

Balance Sheet

Concept	2015 Q4	2015 Q3	2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$377.4M	$394.1M	$367.3M
YoY Change	8.82%	19.53%	16.31%
Cash & Equivalents	$336.2M	$355.4M	$331.1M
Short-Term Investments	$41.20M	$38.70M	$36.20M
Other Short-Term Assets	$11.70M	$20.90M	$13.80M
YoY Change	11.43%	77.12%	22.12%
Inventory	$43.63M	$40.68M	$38.23M
Prepaid Expenses
Receivables	$57.85M	$49.24M	$43.43M
Other Receivables	$14.40M	$8.800M	$8.300M
Total Short-Term Assets	$505.0M	$513.7M	$471.1M
YoY Change	16.76%	21.01%	14.15%
LONG-TERM ASSETS
Property, Plant & Equipment	$74.32M	$78.77M	$81.38M
YoY Change	-13.67%	-11.03%	-11.45%
Goodwill	$6.463M	$1.478M	$1.478M
YoY Change	337.28%	0.0%	0.0%
Intangibles	$23.94M	$6.365M	$6.415M
YoY Change	238.89%	-13.92%	-16.34%
Long-Term Investments
YoY Change
Other Assets	$17.10M	$9.900M	$9.900M
YoY Change	83.87%	70.69%	70.69%
Total Long-Term Assets	$121.8M	$96.53M	$99.19M
YoY Change	12.2%	-6.47%	-7.19%
TOTAL ASSETS
Total Short-Term Assets	$505.0M	$513.7M	$471.1M
Total Long-Term Assets	$121.8M	$96.53M	$99.19M
Total Assets	$626.8M	$610.2M	$570.2M
YoY Change	15.84%	15.64%	9.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$13.67M	$14.73M	$12.59M
YoY Change	20.14%	23.47%	11.11%
Accrued Expenses	$28.95M	$22.47M	$16.09M
YoY Change	66.85%	29.76%	1.85%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$42.62M	$37.20M	$28.68M
YoY Change	48.35%	27.19%	5.72%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$3.000M	$2.800M	$1.200M
YoY Change	11.11%	3.7%	-55.56%
Total Long-Term Liabilities	$3.000M	$2.800M	$1.200M
YoY Change	11.11%	3.7%	-55.56%
TOTAL LIABILITIES
Total Short-Term Liabilities	$42.62M	$37.20M	$28.68M
Total Long-Term Liabilities	$3.000M	$2.800M	$1.200M
Total Liabilities	$47.00M	$43.10M	$32.20M
YoY Change	42.86%	18.73%	-5.57%
SHAREHOLDERS EQUITY
Retained Earnings	$453.9M	$448.4M	$432.2M
YoY Change	11.0%	11.68%	9.38%
Common Stock	$146.7M	$136.0M	$123.7M
YoY Change	34.75%	42.51%	37.18%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$0.00
YoY Change
Treasury Stock Shares	0.000 shares
Shareholders Equity	$579.9M	$567.2M	$538.1M
YoY Change
Total Liabilities & Shareholders Equity	$626.8M	$610.2M	$570.2M
YoY Change	15.84%	15.64%	9.76%

Cashflow Statement

Concept	2015 Q4	2015 Q3	2015 Q2
OPERATING ACTIVITIES
Net Income	$5.463M	$16.27M	$13.57M
YoY Change	-25.9%	153.05%	130.86%
Depreciation, Depletion And Amortization	$4.800M	$4.300M	$4.400M
YoY Change	0.0%	-12.24%	-10.2%
Cash From Operating Activities	$6.300M	$19.40M	$15.90M
YoY Change	-48.78%	2.11%	-4.22%
INVESTING ACTIVITIES
Capital Expenditures	-$5.400M	-$3.100M	-$2.800M
YoY Change	170.0%	24.0%	-60.56%
Acquisitions
YoY Change
Other Investing Activities	-$31.00M	$1.200M	$9.900M
YoY Change	-684.91%	71.43%	-335.71%
Cash From Investing Activities	-$36.40M	-$1.900M	$7.100M
YoY Change	-1170.59%	0.0%	-162.83%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	13.40M	6.200M	-2.000M
YoY Change	24.07%	58.97%	-154.05%
NET CHANGE
Cash From Operating Activities	6.300M	19.40M	15.90M
Cash From Investing Activities	-36.40M	-1.900M	7.100M
Cash From Financing Activities	13.40M	6.200M	-2.000M
Net Change In Cash	-16.70M	23.70M	21.00M
YoY Change	-163.02%	12.86%	133.33%
FREE CASH FLOW
Cash From Operating Activities	$6.300M	$19.40M	$15.90M
Capital Expenditures	-$5.400M	-$3.100M	-$2.800M
Free Cash Flow	$11.70M	$22.50M	$18.70M
YoY Change	-18.18%	4.65%	-21.1%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2016	dei	Amendment Flag AmendmentFlag	false
CY2016	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2016	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2016	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
CY2016	dei	Document Period End Date DocumentPeriodEndDate	2016-12-31
CY2016	dei	Document Type DocumentType	10-K
CY2016	dei	Entity Central Index Key EntityCentralIndexKey	0000883984
CY2017Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	16338132	shares
CY2016	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2016	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2016Q2	dei	Entity Public Float EntityPublicFloat	1643877298	USD
CY2016	dei	Entity Registrant Name EntityRegistrantName	ICU MEDICAL INC/DE
CY2016	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2016	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2015Q4	icui	Accrued Salaries And Benefits AccruedSalariesAndBenefits	6875000	USD
CY2016Q4	icui	Accrued Salaries And Benefits AccruedSalariesAndBenefits	5702000	USD
CY2015Q4	icui	Accrued Value Added Tax AccruedValueAddedTax	993000	USD
CY2016Q4	icui	Accrued Value Added Tax AccruedValueAddedTax	1472000	USD
CY2016Q4	icui	Espp Annual Issuance Increase Limit ESPPAnnualIssuanceIncreaseLimit	300000	shares
CY2016Q4	icui	Espp Original Issuance ESPPOriginalIssuance	750000	shares
CY2014	icui	Effectiveincometaxratereconciliation Asu201609 EffectiveincometaxratereconciliationASU201609	0	USD
CY2015	icui	Effectiveincometaxratereconciliation Asu201609 EffectiveincometaxratereconciliationASU201609	0	USD
CY2016	icui	Effectiveincometaxratereconciliation Asu201609 EffectiveincometaxratereconciliationASU201609	-7720000	USD
CY2014	icui	Effectiveincometaxratereconciliationpercent Asu201609 EffectiveincometaxratereconciliationpercentASU201609	0.000
CY2015	icui	Effectiveincometaxratereconciliationpercent Asu201609 EffectiveincometaxratereconciliationpercentASU201609	0.000
CY2016	icui	Effectiveincometaxratereconciliationpercent Asu201609 EffectiveincometaxratereconciliationpercentASU201609	0.091
CY2015	icui	Grosslegalsettlementaward Grosslegalsettlementaward	8800000	USD
CY2014	icui	Increase Decreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes	4327000	USD
CY2015	icui	Increase Decreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes	1613000	USD
CY2016	icui	Increase Decreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes	714000	USD
CY2014	icui	Indirect Tax Benefit From Stock Options IndirectTaxBenefitFromStockOptions	209000	USD
CY2015	icui	Indirect Tax Benefit From Stock Options IndirectTaxBenefitFromStockOptions	1997000	USD
CY2016	icui	Indirect Tax Benefit From Stock Options IndirectTaxBenefitFromStockOptions	0	USD
CY2015	icui	Legal Settlement Charge For Legal Fees LegalSettlementChargeForLegalFees	700000	USD
CY2015	icui	Legalsettlementcharge Legalsettlementcharge	6500000	USD
CY2014	icui	Legalsettlementsincludingamountsawardedinadisputeandchargesamountspaidoutinaseparatedispute. Legalsettlementsincludingamountsawardedinadisputeandchargesamountspaidoutinaseparatedispute.	0	USD
CY2015	icui	Legalsettlementsincludingamountsawardedinadisputeandchargesamountspaidoutinaseparatedispute. Legalsettlementsincludingamountsawardedinadisputeandchargesamountspaidoutinaseparatedispute.	1798000	USD
CY2016	icui	Legalsettlementsincludingamountsawardedinadisputeandchargesamountspaidoutinaseparatedispute. Legalsettlementsincludingamountsawardedinadisputeandchargesamountspaidoutinaseparatedispute.	0	USD
CY2015Q4	icui	Miscellaneousacquisitionrelatedaccrual Miscellaneousacquisitionrelatedaccrual	1604000	USD
CY2016Q4	icui	Miscellaneousacquisitionrelatedaccrual Miscellaneousacquisitionrelatedaccrual	2750000	USD
CY2015Q4	icui	Net Book Valueof Building NetBookValueofBuilding	2500000	USD
CY2015	icui	Netlegalsettlement Netlegalsettlement	5300000	USD
CY2015Q4	icui	Noncurrentdeferredtaxasset Noncurrentdeferredtaxasset	17099000	USD
CY2016Q4	icui	Noncurrentdeferredtaxasset Noncurrentdeferredtaxasset	21935000	USD
CY2015Q4	icui	Outsidesalescommissions Outsidesalescommissions	1023000	USD
CY2016Q4	icui	Outsidesalescommissions Outsidesalescommissions	1141000	USD
CY2014	icui	Provision For Warranty And Returns ProvisionForWarrantyAndReturns	-360000	USD
CY2015	icui	Provision For Warranty And Returns ProvisionForWarrantyAndReturns	52000	USD
CY2016	icui	Provision For Warranty And Returns ProvisionForWarrantyAndReturns	559000	USD
CY2014	icui	Restructuringandstrategictransactionexpense Restructuringandstrategictransactionexpense	5093000	USD
CY2015	icui	Restructuringandstrategictransactionexpense Restructuringandstrategictransactionexpense	8451000	USD
CY2016	icui	Restructuringandstrategictransactionexpense Restructuringandstrategictransactionexpense	15348000	USD
CY2015	icui	Saleofassetsacquiredinacquisition Saleofassetsacquiredinacquisition	28970000	USD
CY2015Q4	icui	Sellingpriceofbuilding Sellingpriceofbuilding	3600000	USD
CY2016Q4	icui	Shares Available In Employee Stock Purchase Plan SharesAvailableInEmployeeStockPurchasePlan	156913	shares
CY2014	icui	Strategic Transaction Costs StrategicTransactionCosts	1600000	USD
CY2015	icui	Strategic Transaction Costs StrategicTransactionCosts	1800000	USD
CY2016	icui	Strategic Transaction Costs StrategicTransactionCosts	14300000	USD
CY2016	icui	Unrecognized Compensation Expense Espp UnrecognizedCompensationExpenseESPP	100000	USD
CY2015	icui	Valueofoptionexerciseswithsharesremittedtothecompanyinlieuofcashpayment Valueofoptionexerciseswithsharesremittedtothecompanyinlieuofcashpayment	100000	USD
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	13670000	USD
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	14641000	USD
CY2015Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	57847000	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	56161000	USD
CY2015Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	8302000	USD
CY2016Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	7912000	USD
CY2015Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	28948000	USD
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	25896000	USD
CY2015Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	394000	USD
CY2016Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	4177000	USD
CY2015Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	148728000	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	158259000	USD
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-20758000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-21272000	USD
CY2015	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P14Y0M
CY2015Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	145125000	USD
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	162828000	USD
CY2014	us-gaap	Advertising Expense AdvertisingExpense	100000	USD
CY2015	us-gaap	Advertising Expense AdvertisingExpense	200000	USD
CY2016	us-gaap	Advertising Expense AdvertisingExpense	100000	USD
CY2015Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1101000	USD
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1073000	USD
CY2014	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2400000	USD
CY2015	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2200000	USD
CY2016	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2800000	USD
CY2014	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	16000	shares
CY2016	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2015Q4	us-gaap	Assets Assets	626825000	USD
CY2016Q4	us-gaap	Assets Assets	704688000	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	505007000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	569097000	USD
CY2015Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	4134000	USD
CY2016Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	0	USD
CY2015Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	41233000	USD
CY2015Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	41233000	USD
CY2016Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	0	USD
CY2015Q4	us-gaap	Business Acquisition Percentage Of Voting Interests Acquired BusinessAcquisitionPercentageOfVotingInterestsAcquired	1.00
CY2014	us-gaap	Business Combination Bargain Purchase Gain Recognized Amount BusinessCombinationBargainPurchaseGainRecognizedAmount	0	USD
CY2015	us-gaap	Business Combination Bargain Purchase Gain Recognized Amount BusinessCombinationBargainPurchaseGainRecognizedAmount	0	USD
CY2016	us-gaap	Business Combination Bargain Purchase Gain Recognized Amount BusinessCombinationBargainPurchaseGainRecognizedAmount	1456000	USD
CY2015	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	56786000	USD
CY2015Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets	254000	USD
CY2015Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Assets Noncurrent BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssetsNoncurrent	4426000	USD
CY2015Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	56786000	USD
CY2015Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment	3982000	USD
CY2014	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	789000	USD
CY2015	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	182000	USD
CY2016	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1566000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	226022000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	275812000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	336164000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	445082000	USD
CY2014	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	49790000	USD
CY2015	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	60352000	USD
CY2016	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	108918000	USD
CY2015Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	377397000	USD
CY2016Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	445082000	USD
CY2015Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.1
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.1
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16086000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16337763	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16086000	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16337670	shares
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	1608000	USD
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	1633000	USD
CY2014	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	14588000	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	33781000	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	62570000	USD
CY2015Q4	us-gaap	Convertible Preferred Stock Nonredeemable Or Redeemable Issuer Option Value ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue	0	USD
CY2016Q4	us-gaap	Convertible Preferred Stock Nonredeemable Or Redeemable Issuer Option Value ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue	0	USD
CY2014	us-gaap	Cost Of Goods Sold CostOfGoodsSold	157859000	USD
CY2015	us-gaap	Cost Of Goods Sold CostOfGoodsSold	160871000	USD
CY2016	us-gaap	Cost Of Goods Sold CostOfGoodsSold	177974000	USD
CY2014	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	13860000	USD
CY2015	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	18601000	USD
CY2016	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	21123000	USD
CY2014	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	2100000	USD
CY2015	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	1426000	USD
CY2016	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	1118000	USD
CY2014	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	14655000	USD
CY2015	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	20772000	USD
CY2016	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	24588000	USD
CY2014	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-1305000	USD
CY2015	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	745000	USD
CY2016	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2347000	USD
CY2014	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-2325000	USD
CY2015	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	4524000	USD
CY2016	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-2045000	USD
CY2014	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	139000	USD
CY2015	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	378000	USD
CY2016	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	304000	USD
CY2014	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1198000	USD
CY2015	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	3942000	USD
CY2016	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2508000	USD
CY2014	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	988000	USD
CY2015	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-960000	USD
CY2016	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-767000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	17099000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	21935000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	1372000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	1370000	USD
CY2014	us-gaap	Depreciation Depreciation	17000000	USD
CY2015	us-gaap	Depreciation Depreciation	15900000	USD
CY2016	us-gaap	Depreciation Depreciation	16300000	USD
CY2014	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	19447000	USD
CY2015	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	18073000	USD
CY2016	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	19050000	USD
CY2014	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.72
CY2015Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.62
CY2015Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.86
CY2015Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.02
CY2015Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.34
CY2015	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.84
CY2016Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.99
CY2016Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.03
CY2016Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.16
CY2016Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.58
CY2016	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.90
CY2014	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.68
CY2015Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.60
CY2015Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.83
CY2015Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.98
CY2015Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.33
CY2015	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.73
CY2016Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.96
CY2016Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.98
CY2016Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.09
CY2016Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.54
CY2016	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.66
CY2014	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-8447000	USD
CY2015	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-8282000	USD
CY2016	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	224000	USD
CY2014	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.338
CY2015	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.355
CY2016	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.259
CY2014	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350
CY2015	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350
CY2016	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Deductions Qualified Production Activities EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities	0.002
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Deductions Qualified Production Activities EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities	0.001
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Deductions Qualified Production Activities EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities	0.008
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.001
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.049
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.001
CY2014	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.025
CY2015	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.039
CY2016	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.021
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.040
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.084
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.012
CY2016Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	16800000	USD
CY2016	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P0Y8M
CY2014	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	3567000	USD
CY2015	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	4922000	USD
CY2016	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	5682000	USD
CY2014	us-gaap	Employee Service Share Based Compensation Tax Benefit Realized From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptions	5700000	USD
CY2015	us-gaap	Employee Service Share Based Compensation Tax Benefit Realized From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptions	9330000	USD
CY2016	us-gaap	Employee Service Share Based Compensation Tax Benefit Realized From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptions	7556000	USD
CY2015	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	60693000	USD
CY2016	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	3306000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	21763000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	24542000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	11024000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2719000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1925000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	2008000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2147000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2560000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	45699000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	46925000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	23936000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	22383000	USD
CY2015	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	18076000	USD
CY2014	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	100000	USD
CY2015	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	200000	USD
CY2016	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	300000	USD
CY2014	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	USD
CY2015	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	1086000	USD
CY2016	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	USD
CY2014	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-8000	USD
CY2015Q4	us-gaap	Goodwill Goodwill	6463000	USD
CY2015	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	1106000	USD
CY2016	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-59000	USD
CY2014Q4	us-gaap	Goodwill Goodwill	1478000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	5577000	USD
CY2015	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	4985000	USD
CY2016	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	USD
CY2015	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2016	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2015	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	0	USD
CY2016	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	-886000	USD
CY2014	us-gaap	Gross Profit GrossProfit	151401000	USD
CY2015Q1	us-gaap	Gross Profit GrossProfit	42514000	USD
CY2015Q2	us-gaap	Gross Profit GrossProfit	43761000	USD
CY2015Q3	us-gaap	Gross Profit GrossProfit	46265000	USD
CY2015Q4	us-gaap	Gross Profit GrossProfit	48257000	USD
CY2015	us-gaap	Gross Profit GrossProfit	180797000	USD
CY2016Q1	us-gaap	Gross Profit GrossProfit	49233000	USD
CY2016Q2	us-gaap	Gross Profit GrossProfit	50132000	USD
CY2016Q3	us-gaap	Gross Profit GrossProfit	51273000	USD
CY2016Q4	us-gaap	Gross Profit GrossProfit	50760000	USD
CY2016	us-gaap	Gross Profit GrossProfit	201398000	USD
CY2014	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	USD
CY2015	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	4139000	USD
CY2016	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	728000	USD
CY2014	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	39792000	USD
CY2015	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	69699000	USD
CY2016	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	85164000	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	33508000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	74288000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	80714000	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	6284000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-4589000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	4450000	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	39792000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	69699000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	85164000	USD
CY2014	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	13457000	USD
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	24714000	USD
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	22080000	USD
CY2014	us-gaap	Income Tax Reconciliation Deductions Qualified Production Activities IncomeTaxReconciliationDeductionsQualifiedProductionActivities	101000	USD
CY2015	us-gaap	Income Tax Reconciliation Deductions Qualified Production Activities IncomeTaxReconciliationDeductionsQualifiedProductionActivities	107000	USD
CY2016	us-gaap	Income Tax Reconciliation Deductions Qualified Production Activities IncomeTaxReconciliationDeductionsQualifiedProductionActivities	653000	USD
CY2014	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	39000	USD
CY2015	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	3412000	USD
CY2016	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-135000	USD
CY2014	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	13927000	USD
CY2015	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	24395000	USD
CY2016	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	29807000	USD
CY2014	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	981000	USD
CY2015	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	2661000	USD
CY2016	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	1795000	USD
CY2014	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	1591000	USD
CY2015	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	5861000	USD
CY2016	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	1014000	USD
CY2014	us-gaap	Income Taxes Paid IncomeTaxesPaid	8668000	USD
CY2015	us-gaap	Income Taxes Paid IncomeTaxesPaid	22998000	USD
CY2016	us-gaap	Income Taxes Paid IncomeTaxesPaid	21101000	USD
CY2014	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-621000	USD
CY2015	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3118000	USD
CY2016	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-463000	USD
CY2014	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-4912000	USD
CY2015	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	20515000	USD
CY2016	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-744000	USD
CY2016	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	200000	USD
CY2014	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2344000	USD
CY2015	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	9454000	USD
CY2016	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1221000	USD
CY2014	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3836000	USD
CY2015	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	8337000	USD
CY2016	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5501000	USD
CY2014	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1970000	USD
CY2015	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1832000	USD
CY2016	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3028000	USD
CY2015Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	23936000	USD
CY2016Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	22383000	USD
CY2015Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	14669000	USD
CY2016Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	16414000	USD
CY2015Q4	us-gaap	Inventory Net InventoryNet	43632000	USD
CY2016Q4	us-gaap	Inventory Net InventoryNet	49264000	USD
CY2015Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	24681000	USD
CY2016Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	28435000	USD
CY2015Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	4282000	USD
CY2016Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	4415000	USD
CY2014	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	2188000	USD
CY2015	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	1670000	USD
CY2016	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	1355000	USD
CY2014	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	400000	USD
CY2015	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	500000	USD
CY2016	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	900000	USD
CY2014	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	200000	USD
CY2015	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	400000	USD
CY2016	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	600000	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	626825000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	704688000	USD
CY2015	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	3907000	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	42618000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	40537000	USD
CY2015Q4	us-gaap	Liabilities Other Than Longterm Debt Noncurrent LiabilitiesOtherThanLongtermDebtNoncurrent	1476000	USD
CY2016Q4	us-gaap	Liabilities Other Than Longterm Debt Noncurrent LiabilitiesOtherThanLongtermDebtNoncurrent	1107000	USD
CY2015Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	1488000	USD
CY2016Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	1519000	USD
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	13647000	USD
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	15681000	USD
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2472000	USD
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-21750000	USD
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-11242000	USD
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	16281000	USD
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	66340000	USD
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	64195000	USD
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	89941000	USD
CY2014	us-gaap	Net Income Loss NetIncomeLoss	26335000	USD
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	9686000	USD
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	13570000	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	16266000	USD
CY2015Q4	us-gaap	Net Income Loss NetIncomeLoss	5463000	USD
CY2015	us-gaap	Net Income Loss NetIncomeLoss	44985000	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	16606000	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	18806000	USD
CY2016Q4	us-gaap	Net Income Loss NetIncomeLoss	9512000	USD
CY2016	us-gaap	Net Income Loss NetIncomeLoss	63084000	USD
CY2015	us-gaap	Noncash Or Part Noncash Acquisition Payables Assumed1 NoncashOrPartNoncashAcquisitionPayablesAssumed1	3907000	USD
CY2016	us-gaap	Noncash Or Part Noncash Acquisition Payables Assumed1 NoncashOrPartNoncashAcquisitionPayablesAssumed1	734000	USD
CY2014	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	755000	USD
CY2015	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1134000	USD
CY2016	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	767000	USD
CY2014	us-gaap	Operating Expenses OperatingExpenses	112364000	USD
CY2015	us-gaap	Operating Expenses OperatingExpenses	112232000	USD
CY2016	us-gaap	Operating Expenses OperatingExpenses	118457000	USD
CY2014	us-gaap	Operating Income Loss OperatingIncomeLoss	39037000	USD
CY2015	us-gaap	Operating Income Loss OperatingIncomeLoss	68565000	USD
CY2016	us-gaap	Operating Income Loss OperatingIncomeLoss	82941000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	1737000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	554000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	175000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	338000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	333000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	337000	USD
CY2016Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	4100000	USD
CY2015Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3218000	USD
CY2016Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2319000	USD
CY2014	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-11747000	USD
CY2015	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-11204000	USD
CY2016	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-514000	USD
CY2014	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-11747000	USD
CY2015	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-11204000	USD
CY2016	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-514000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-3129000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-2680000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	185000	USD
CY2014	us-gaap	Other Noncash Expense OtherNoncashExpense	0	USD
CY2015	us-gaap	Other Noncash Expense OtherNoncashExpense	0	USD
CY2016	us-gaap	Other Noncash Expense OtherNoncashExpense	75000	USD
CY2016	us-gaap	Other Restructuring Costs OtherRestructuringCosts	200000	USD
CY2014	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	490000	USD
CY2015	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	414000	USD
CY2016	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	33000	USD
CY2015	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	7500000	USD
CY2014	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	5836000	USD
CY2015	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1523000	USD
CY2016	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	17235000	USD
CY2015	us-gaap	Payments For Restructuring PaymentsForRestructuring	1506000	USD
CY2016	us-gaap	Payments For Restructuring PaymentsForRestructuring	5869000	USD
CY2015	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1500000	USD
CY2016	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1900000	USD
CY2014	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2015	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	56786000	USD
CY2016	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	2584000	USD
CY2014	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	989000	USD
CY2015	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	951000	USD
CY2016	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1192000	USD
CY2014	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	93588000	USD
CY2015	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	56137000	USD
CY2016	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	118384000	USD
CY2014	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	16604000	USD
CY2015	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	12984000	USD
CY2016	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	23361000	USD
CY2014	us-gaap	Pension And Other Postretirement Benefit Expense PensionAndOtherPostretirementBenefitExpense	1300000	USD
CY2015	us-gaap	Pension And Other Postretirement Benefit Expense PensionAndOtherPostretirementBenefitExpense	1300000	USD
CY2016	us-gaap	Pension And Other Postretirement Benefit Expense PensionAndOtherPostretirementBenefitExpense	1500000	USD
CY2015Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2015Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	28970000	USD
CY2016	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	USD
CY2016	us-gaap	Proceeds From Sale Of Buildings ProceedsFromSaleOfBuildings	3300000	USD
CY2014	us-gaap	Proceeds From Sale Of Other Productive Assets ProceedsFromSaleOfOtherProductiveAssets	0	USD
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7631000	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7355000	USD
CY2015Q4	us-gaap	Prepaid Taxes PrepaidTaxes	14366000	USD
CY2016Q4	us-gaap	Prepaid Taxes PrepaidTaxes	11235000	USD
CY2014	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	USD
CY2015	us-gaap	Proceeds From Sale Of Other Productive Assets ProceedsFromSaleOfOtherProductiveAssets	0	USD
CY2016	us-gaap	Proceeds From Sale Of Other Productive Assets ProceedsFromSaleOfOtherProductiveAssets	3268000	USD
CY2014	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	89426000	USD
CY2015	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	83054000	USD
CY2016	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	158534000	USD
CY2014	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	5000	USD
CY2015	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	3592000	USD
CY2016	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	0	USD
CY2015	us-gaap	Proceeds From Sales Of Business Affiliate And Productive Assets ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets	29000000	USD
CY2014	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	16998000	USD
CY2015	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	15042000	USD
CY2016	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	17346000	USD
CY2014	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	2485000	USD
CY2015	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	2162000	USD
CY2016	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	2361000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	223048000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	243955000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	74320000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	85696000	USD
CY2014	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	34000	USD
CY2015	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	54000	USD
CY2016	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	USD
CY2014	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	18332000	USD
CY2015	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	15714000	USD
CY2016	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12955000	USD
CY2014	us-gaap	Restructuring Charges RestructuringCharges	3500000	USD
CY2015	us-gaap	Restructuring Charges RestructuringCharges	6700000	USD
CY2016	us-gaap	Restructuring Charges RestructuringCharges	800000	USD
CY2015	us-gaap	Restructuring Costs RestructuringCosts	6676000	USD
CY2016	us-gaap	Restructuring Costs RestructuringCosts	774000	USD
CY2015Q4	us-gaap	Restructuring Reserve RestructuringReserve	6539000	USD
CY2016Q4	us-gaap	Restructuring Reserve RestructuringReserve	1530000	USD
CY2016	us-gaap	Restructuring Reserve Accrual Adjustment1 RestructuringReserveAccrualAdjustment1	-48000	USD
CY2014Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	1369000	USD
CY2015Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	6539000	USD
CY2016Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	423000	USD
CY2016	us-gaap	Restructuring Reserve Translation Adjustment RestructuringReserveTranslationAdjustment	134000	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	453896000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	516980000	USD
CY2014	us-gaap	Revenues Revenues	309260000	USD
CY2015	us-gaap	Revenues Revenues	341668000	USD
CY2016	us-gaap	Revenues Revenues	379372000	USD
CY2014	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	308770000	USD
CY2015	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	341254000	USD
CY2016	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	379339000	USD
CY2015Q1	us-gaap	Sales Revenue Net SalesRevenueNet	81484000	USD
CY2015Q2	us-gaap	Sales Revenue Net SalesRevenueNet	83781000	USD
CY2015Q3	us-gaap	Sales Revenue Net SalesRevenueNet	86016000	USD
CY2015Q4	us-gaap	Sales Revenue Net SalesRevenueNet	90387000	USD
CY2016Q1	us-gaap	Sales Revenue Net SalesRevenueNet	89855000	USD
CY2016Q2	us-gaap	Sales Revenue Net SalesRevenueNet	96721000	USD
CY2016Q3	us-gaap	Sales Revenue Net SalesRevenueNet	97108000	USD
CY2016Q4	us-gaap	Sales Revenue Net SalesRevenueNet	95688000	USD
CY2014	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	88939000	USD
CY2015	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	83216000	USD
CY2016	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	89426000	USD
CY2014	us-gaap	Share Based Compensation ShareBasedCompensation	9592000	USD
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	12827000	USD
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	15242000	USD
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	2763300	shares
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	18802000	USD
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	28071000	USD
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	25065000	USD
CY2016Q4	us-gaap	Share Price SharePrice	147.35
CY2016	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	20261	shares
CY2014	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	22698000	USD
CY2015	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	24372000	USD
CY2016	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	17346000	USD
CY2016Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	40000000	USD
CY2016Q4	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	7200000	USD
CY2015	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	5600000	USD
CY2016	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	15400000	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	464725000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	508252000	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	579871000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	660155000	USD
CY2015Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	579871000	USD
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	660155000	USD
CY2015Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	0	shares
CY2016Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	93	shares
CY2015Q4	us-gaap	Treasury Stock Value TreasuryStockValue	0	USD
CY2016Q4	us-gaap	Treasury Stock Value TreasuryStockValue	14000	USD
CY2014	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	5836000	USD
CY2015	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	1523000	USD
CY2016	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	17235000	USD
CY2015Q4	us-gaap	Undistributed Earnings Of Foreign Subsidiaries UndistributedEarningsOfForeignSubsidiaries	17800000	USD
CY2016Q4	us-gaap	Undistributed Earnings Of Foreign Subsidiaries UndistributedEarningsOfForeignSubsidiaries	10800000	USD
CY2013Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	5544000	USD
CY2014Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4115000	USD
CY2015Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1772000	USD
CY2016Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2000000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2015	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	2399000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	46000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	2113000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	314000	USD
CY2016Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2000000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	0	USD
CY2014	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	661000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	345000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	345000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	217000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	25000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	77000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	194000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	0	USD
CY2016	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	148000	USD
CY2014	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	365000	shares
CY2015	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	648000	shares
CY2016	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1086000	shares
CY2014	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15647000	shares
CY2015	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16496000	shares
CY2016	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17254000	shares
CY2014	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15282000	shares
CY2015	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15848000	shares
CY2016	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16168000	shares
CY2016	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Recently Issued Accounting Standards</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"></font><font style="font-family:inherit;font-size:10pt;">In October 2016, the FASB issued No. ASU 2016-16, Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory. Current generally accepted accounting principles prohibits the recognition of current and deferred income taxes for an intra-entity asset transfer until after the asset has been sold to an outside party. The amendments in ASU 2016-16 eliminates this prohibition. Accordingly, an entity should recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs. Amendments in this update are effective for annual reporting periods beginning after December 15, 2017. Early adoption is permitted in the first interim period of an annual reporting period. The amendments should be applied on a modified retrospective basis through a cumulative-effect adjustment directly to retained earnings as of the beginning of the period of adoption. We are currently evaluating the impact of this ASU on the consolidated financial statements and related disclosures. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2016, the FASB issued No. ASU 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments. ASU 2016-15</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> </font><font style="font-family:inherit;font-size:10pt;">provides specific guidance on eight cash flow issues where current guidance is unclear or does not include any specifics on classification. The eight specific cash flow issues are: debt prepayment or debt extinguishment costs; settlement of zero-coupon debt instruments or other debt instruments with zero coupon interest rates that are insignificant in relation to the effective interest rate of the borrowing; contingent consideration payments made after a business combination; proceeds from the settlement of insurance claims; proceeds from the settlement of corporate-owned life insurance policies, including bank-owned policies; distributions received from equity method investees; beneficial interests in securitization transactions; and separately identifiable cash flows and application of the predominance principle. The amendments in ASU 2016-15 are effective for annual periods and interim periods within those annual periods beginning after December 15, 2017. Early adoption is permitted. If adopted in an interim period, any adjustments should be reflected as of the beginning of the fiscal year that includes the interim period. Amendments should be applied using a retrospective transition method to each period presented. We are currently evaluating the impact of this ASU on the consolidated financial statements and related disclosures. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2016, the FASB issued No. ASU 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. This update amends the FASB's guidance on the impairment of financial instruments by requiring timelier recording of credit losses on loans and other financial instruments. The ASU adds an impairment model that is based on expected losses rather than incurred losses. The ASU also amends the accounting for credit losses on available-</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">for-sale debt securities and purchased financial assets with credit deterioration. The amendments in this update will be effective for fiscal years beginning after December 15, 2019. Early adoption is permitted as of the fiscal years beginning after December 15, 2018. The updated guidance requires a modified retrospective adoption. We are currently evaluating the impact of this ASU on the consolidated financial statements and related disclosures.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued No. ASU 2016-02, Leases (Topic 842). The amendments in this update require an entity to recognize a right-of-use asset and lease liability for all leases with terms of more than 12 months. Recognition, measurement and presentation of expenses will depend on classification as finance or operating lease. The amendments also require certain quantitative and qualitative disclosures about leasing arrangements. The amendments in this update will be effective for fiscal years beginning after December 15, 2019. Early adoption is permitted. The updated guidance requires a modified retrospective adoption. We are currently evaluating the impact of this ASU on the consolidated financial statements and related disclosures. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2016, the FASB issued No. ASU 2016-01, Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities, which amends certain aspects of recognition, measurement, presentation and disclosure of financial instruments. This amendment requires all equity investments to be measured at fair value with changes in the fair value recognized through net income (other than those accounted for under the equity method of accounting or those that result in the consolidation of the investee). The amendments in this update will be effective for fiscal years beginning after December 15, 2017. Early adoption of the amendments is not permitted with the exception of the provision requiring the recognition in other comprehensive income the fair value change from instrument-specific credit risk measured using the fair value option for financial instruments. We are currently evaluating the impact of this ASU on the consolidated financial statements and related disclosures. </font></div><div style="line-height:120%;text-align:left;text-indent:96px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">        </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In July 2015, the FASB issued No. ASU No. 2015-11 Inventory (Topic 330): Simplifying the Measurement of Inventory. ASU 2015-11 changes the measurement of inventory from lower of cost or market to lower of cost and net realizable value. The amendments are effective prospectively for the fiscal years, and interim reporting periods within those years, beginning on or after December 15, 2016. We do not anticipate a material impact on our consolidated financial statements from the adoption of this ASU.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606). ASU 2014-09 removes inconsistencies and weaknesses in revenue requirements; provides a more robust framework for addressing revenue issues; improves comparability of revenue recognition practices across entities, industries, jurisdictions and capital markets; provides more useful information to users of financial statements through improved disclosure requirements; and simplifies the preparation of financial statements by reducing the number of requirements to which an entity must refer. This guidance requires that an entity depict the consideration by applying a five-step analysis in determining when and how revenue is recognized. The new model will require revenue recognition to depict the transfer of promised goods or services to customers in an amount that reflects the consideration a company expects to receive in exchange for those goods or services. On April 1, 2015, the FASB voted for a one-year deferral of the effective date of the new revenue recognition standard, ASU 2014-09.  On July 15, 2015, the FASB affirmed these changes, which requires public entities to apply the amendments in ASU 2014-09 for annual reporting beginning after December 15, 2017. Early adoption is permitted beginning after December 31, 2016, the original effective date in ASU 2014-09. Subsequent to the issuance of this ASU, the FASB issued three amendments: ASU No. 2016-08 which clarifies principal versus agent considerations; ASU 2016-10 which clarifies guidance related to identifying performance obligations and licensing implementation; and ASU 2016-12 which provides narrow-scope improvements and practical expedients. All of the amendments have the same effective dates mentioned above. We previously disclosed that we did not anticipate a material impact on our consolidated financial statements from adoption of any of the above ASUs related to Topic 606; we will reassess these ASUs with consideration to their impact on Hospira Infusion Systems ("HIS"). We expect to adopt the full retrospective transition method when adopting this ASU.</font></div></div>
CY2016	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Preparing financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates. </font></div></div>

Files In Submission

Name	View Source	Status
0000883984-17-000013-index-headers.html	Edgar Link	pending
0000883984-17-000013-index.html	Edgar Link	pending
0000883984-17-000013.txt	Edgar Link	pending
0000883984-17-000013-xbrl.zip	Edgar Link	pending
exhibit1016executiveoffice.htm	Edgar Link	pending
exhibit1017non-employeedir.htm	Edgar Link	pending
exhibit21subsidiariesofreg.htm	Edgar Link	pending
exhibit231consentofdeloitt.htm	Edgar Link	pending
exhibit311123116.htm	Edgar Link	pending
exhibit312123116.htm	Edgar Link	pending
exhibit32123116.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
icui-20161231.xml	Edgar Link	completed
icui-20161231.xsd	Edgar Link	pending
icui-20161231_cal.xml	Edgar Link	unprocessable
icui-20161231_def.xml	Edgar Link	unprocessable
icui-20161231_lab.xml	Edgar Link	unprocessable
icui-20161231_pre.xml	Edgar Link	unprocessable
icui1231201610-k.htm	Edgar Link	pending
icui123120_chart-05307a01.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ICUI
ICU MEDICAL INC/DE Stock $icui

2015 Q4 Form 10-K Financial Statement

#000088398417000013 Filed on March 01, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ICUI ICU MEDICAL INC/DE Stock $icui

2015 Q4 Form 10-K Financial Statement

#000088398417000013 Filed on March 01, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ICUI
ICU MEDICAL INC/DE Stock $icui